177 related articles for article (PubMed ID: 36266702)
1. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.
Yi X; Luo L; Zhu Y; Deng H; Liao H; Shen Y; Zheng Y
Cancer Cell Int; 2022 Oct; 22(1):324. PubMed ID: 36266702
[TBL] [Abstract][Full Text] [Related]
2. LINC01117 inhibits invasion and migration of lung adenocarcinoma through influencing EMT process.
Liu L; Ren W; Du L; Xu K; Zhou Y
PLoS One; 2023; 18(6):e0287926. PubMed ID: 37384755
[TBL] [Abstract][Full Text] [Related]
3. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
Front Genet; 2020; 11():547. PubMed ID: 32595698
[TBL] [Abstract][Full Text] [Related]
5.
Wei S; Shao J; Wang J; Zhao T; Liu J; Shen X; Wang Y; Chen H; Wang G
J Thorac Dis; 2022 Jul; 14(7):2652-2664. PubMed ID: 35928621
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma.
Dong B; Wu C; Huang L; Qi Y
Front Cell Dev Biol; 2021; 9():739358. PubMed ID: 34646827
[TBL] [Abstract][Full Text] [Related]
7. LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma.
Zhu J; Weng Y; Wang F; Zhao J
Open Med (Wars); 2022; 17(1):1259-1274. PubMed ID: 35892083
[TBL] [Abstract][Full Text] [Related]
8. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
9. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
Front Oncol; 2021; 11():639600. PubMed ID: 33968738
[TBL] [Abstract][Full Text] [Related]
10. COL11A1-Driven Epithelial-Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail Pathway.
Wang H; Zhou H; Ni H; Shen X
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327583
[TBL] [Abstract][Full Text] [Related]
11. MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A1.
Sun Y; Liu Z; Huang L; Shang Y
J Chemother; 2021 Oct; 33(6):409-419. PubMed ID: 33845716
[TBL] [Abstract][Full Text] [Related]
12. Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163.
Qiu C; Li C; Zheng Q; Fang S; Xu J; Wang H; Guo H
Bioengineered; 2022 May; 13(5):11987-12002. PubMed ID: 35603556
[TBL] [Abstract][Full Text] [Related]
13. High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation.
Wu Z; Zhuo T; Li Z; Zhu Y; Wu J; Liang G; Dai L; Wang Y; Tan X; Chen M
J Cancer; 2023; 14(12):2301-2314. PubMed ID: 37576392
[No Abstract] [Full Text] [Related]
14. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
Tang S; Ni J; Chen B; Sun F; Huang J; Ni S; Tang Z
BMC Cancer; 2022 May; 22(1):525. PubMed ID: 35534807
[TBL] [Abstract][Full Text] [Related]
15. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
Cui Y; Wang X; Zhang L; Liu W; Ning J; Gu R; Cui Y; Cai L; Xing Y
Front Oncol; 2022; 12():974614. PubMed ID: 36185284
[TBL] [Abstract][Full Text] [Related]
16. The Correlation Between SPP1 and Immune Escape of EGFR Mutant Lung Adenocarcinoma Was Explored by Bioinformatics Analysis.
Zheng Y; Hao S; Xiang C; Han Y; Shang Y; Zhen Q; Zhao Y; Zhang M; Zhang Y
Front Oncol; 2021; 11():592854. PubMed ID: 34178613
[TBL] [Abstract][Full Text] [Related]
17. ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma.
Tang Y; Wang T; Zhang A; Zhu J; Zhou T; Zhou YL; Shi J
J Thorac Dis; 2023 Mar; 15(3):1018-1035. PubMed ID: 37065546
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
19. Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial-Mesenchymal Transition.
Wu Y; Liu L; Shen X; Liu W; Ma R
Cancer Manag Res; 2021; 13():559-570. PubMed ID: 33519235
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of
Li B; Li X; Yang Q; Jiang Y; Zhang Q; Zhang J; Cui W; Xu F
Aging (Albany NY); 2024 Feb; 16(3):2953-2977. PubMed ID: 38329443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]